Abrocitinib Therapeutic Cheat Sheet
Abrocitinib is an oral, once-daily selective Janus kinase 1 (JAK1) inhibitor approved for moderate-to-severe atopic dermatitis. It can provide rapid improvement in pruritus and skin disease and is a useful treatment option for many patients. As an oral medication, it may also be preferred by patients who want to avoid injections. When prescribing abrocitinib, it is important to discuss laboratory …
Abrocitinib is an oral, once-daily selective Janus kinase 1 (JAK1) inhibitor approved for moderate-to-severe atopic dermatitis. It can provide rapid improvement in pruritus and skin disease and is a useful treatment option for many patients. As an oral medication, it may also be preferred by patients who want to avoid injections. When prescribing abrocitinib, it is important to discuss laboratory … 
A 2-week-old neonate has multiple blisters and erosions on the scalp, trunk, and extremities since birth. New lesions can be induced by mild friction. A biopsy is obtained from an induced blister and demonstrates cleavage at the dermal-epidermal junction and absent type VII collagen on immunofluorescence. What is the most likely genet … 
The picture shown is most characteristic of what type of epidermolysis bullosa?
A. Junctional epidermolysis bullosa- Non Herlitz type
B. Junctional epidermolysis bullosa- Herlitz type
C. Dowling-Meara form of epidermolysis bullosa simplex
D. Dominant dystrophic epidermolysis bullosa
E. Recessive dystrophic epidermolysis bullosa
To find out the correct answer and read the explan …